Literature DB >> 7421912

Accuracy of the ventricular tachycardia-induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs.

J W Mason, R A Winkle.   

Abstract

We evaluated the prophylactic effect of antiarrhythmic agents against induction of ventricular tachycardia by extrastimulation in 51 patients with recurrent ventricular tachycardia. These patients subsequently underwent 58 long-term trials with tested agents. In 39 trials an agent predicted to be effective by electrophysiologic study was administered, and in 19 a drug predicted to be ineffective was used. There were no clinical differences between the two treatment groups. During a mean follow-up period of 8.2 months, arrhythmias recurred significantly less frequently in the group treated with drugs predicted to be effective than in the other group (P < 0.001); at six months 80 per cent of the patients in the former group were successfully treated, as compared with 33 per cent in the latter group. At 18 months the corresponding figures were 68 per cent and 11 per cent. We conclude that the arrhythmia-induction technique accurately predicts the clinical effectiveness of drugs used in the long-term treatment of recurrent ventricular tachycardia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7421912     DOI: 10.1056/NEJM198011063031901

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  15 in total

1.  A pharmacological challenge predicts reversible rectal sensorimotor dysfunctions in women with fecal incontinence.

Authors:  M Sharma; K Feuerhak; A R Zinsmeister; A E Bharucha
Journal:  Neurogastroenterol Motil       Date:  2018-06-01       Impact factor: 3.598

Review 2.  Therapeutic drug monitoring of antiarrhythmic drugs. Rationale and current status.

Authors:  R Latini; A P Maggioni; A Cavalli
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

3.  What is the solution to sudden cardiac death: calcium modulation or arrhythmia clinics?

Authors:  W T Clusin
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

4.  Recent trends in the management of life-threatening ventricular arrhythmias.

Authors:  B N Singh; J N Weiss; K Nademanee; J H Wittig; P Guzy
Journal:  West J Med       Date:  1984-11

Review 5.  Recent advances in cardiology.

Authors:  E A Rodrigues; D J Coltart
Journal:  Postgrad Med J       Date:  1982-08       Impact factor: 2.401

Review 6.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

Review 7.  Therapeutic drug monitoring of antiarrhythmic agents.

Authors:  J E Brown; D G Shand
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

Review 8.  Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.

Authors:  A Fitton; M T Buckley
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

9.  A computer model study of the ventricular fibrillation vulnerable window: sensitivity to regional conduction depressions.

Authors:  M G Fishler; N V Thakor
Journal:  Ann Biomed Eng       Date:  1994 Nov-Dec       Impact factor: 3.934

10.  Operative therapy of malignant ventricular rhythm disturbances.

Authors:  J M Moran; R F Kehoe; J M Loeb; J H Sanders; C L Tommaso; L L Michaelis
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.